. (2022). Discontinuation of Inhaled Corticosteroids from Triple Therapy in COPD: Effects on Major Outcomes in Real World Clinical Practice. Copd, 19, 133-141. http://doi.org/10.1080/15412555.2022.2045265
S. Suissa
First name
S.
Last name
Suissa
. (2022). Fluticasone-Based versus Budesonide-Based Triple Therapies in COPD: Real-World Comparative Effectiveness and Safety. Copd, 19, 109-117. http://doi.org/10.1080/15412555.2022.2035705
. (2022). Reduction of Cardiovascular Disease and Mortality versus Risk of New Onset Diabetes with Statin Use in Patients with Rheumatoid Arthritis. Arthritis Care Res (Hoboken). http://doi.org/10.1002/acr.24866
. (2003). The use of inhaled corticosteroids in the United Kingdom and the Netherlands. Respir Med.
. (2005). Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease. Jama. http://doi.org/10.1001/jama.294.23.2989
. (2006). Use of first- and second-generation cyclooxygenase-2-selective nonsteroidal antiinflammatory drugs and risk of acute myocardial infarction. Circulation. http://doi.org/10.1161/circulationaha.105.602425
. (2006). Cyclooxygenase-2 selective nonsteroidal anti-inflammatory drugs and the risk of ischemic stroke: a nested case-control study. Stroke. http://doi.org/10.1161/01.str.0000226642.55207.94
. (2007). The impact of over-the-counter simvastatin on the number of statin prescriptions in the United Kingdom: a view from the General Practice Research Database. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.1314
. (2007). Dopamine agonists and the risk of cardiac-valve regurgitation. N Engl J Med. http://doi.org/10.1056/NEJMoa062222
. (2007). Drug drug interactions between antithrombotic medications and the risk of gastrointestinal bleeding. Cmaj. http://doi.org/10.1503/cmaj.070186